Human endothelial cell attachment and proliferation on a novel vascular graft prototype
✍ Scribed by Knetsch, Menno L. W. ;Aldenhoff, Yvette B. J. ;Schraven, Martijn ;Koole, Leo H.
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 414 KB
- Volume
- 71A
- Category
- Article
- ISSN
- 0021-9304
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A new vascular prosthesis prototype was assessed for its ability to support an endothelial cell layer in vitro. A coiled tubular structure, constructed from polymer‐coated metallic wires, with an internal diameter of 690 μm, was used. Addition of heparin to the surface coating of the coil strongly enhanced the blood compatibility of the device. A series of coils with five different coatings, increasing in hydrophilicity, was studied. Heparin was added to one series, another series did not contain this anticoagulant drug. Upon contact with blood, a vascular prosthesis will instantaneously adsorb plasma proteins on its surface, and these proteins will influence the behavior of cells binding to the device. When coils were treated with human plasma proteins, mimicking the in vivo situation, human microvascular endothelial cells grew well on all coils studied, irrespective of the hydrophilicity of the underlying coating or the addition of heparin. For control coils, only endothelial cell growth on the most hydrophobic surfaces, and a moderate enhancing effect for heparin, were observed. This novel vascular graft prototype seems well suited for the support of an endothelial cell layer, especially when plasma proteins are adsorbed to its surface, and shows promise for in vivo testing. © 2004 Wiley Periodicals, Inc. J Biomed Mater Res 71A: 615–624, 2004
📜 SIMILAR VOLUMES
The binding, internalization, and metabolism of 13H]-heparin by human umbilical vein endothelial cells (HUVEC) and human umbilical arterial smooth muscle cells (HUASMC) have been characterized using 5ize-exclusion HPLC. Incubation of HUVEC with ['HI-heparin demonstrated selective binding of high-mol
## Abstract **Summary:** Tissue engineering offers the potential of providing vessels that can be used to replace diseased and damaged native blood vessels. The endothelization of a synthetic vascular graft minimizes the failures associated with blood clotting and platelet activation. The aim of th
## Abstract Angiogenesis is essential in bone fracture healing for restoring blood flow to the fracture site. Vascular endothelial growth factor (VEGF) and its receptor have been implicated in this process. Despite the importance of angiogenesis for the healing processes of damaged bones, the role
Regional administration of high doses of tumor necrosis factor (TNF), interferon gamma (IFNgamma) and melphalan to patients with advanced cancers of the limbs, results in rapid and specific tumor necrosis, while the normal adjacent tissues remain unaffected. The tumor vasculature is selectively dest